Switzerland Overtaken Germany as Europes Most Innovative Drug Delivery Market

26 August 2019

GMP News

Provisional findings from the Pharmapack innovation Index is showing that innovation in drug delivery is accelerating across Europe – and that Switzerland has overtaken Germany as Europe’s most innovative drug delivery market.

This research points to a continued acceleration of new device innovation and packaging solutions entering the market. All six major European markets (Switzerland, Germany, UK, France, Italy and Spain) saw increases in ‘innovation potential’ according to industry executives – notably closing on the United States as the world leader. On average innovation potential has increased by 4% year-on-year, with the United Kingdom (5%) and Switzerland (10%) showing the biggest overall gains.

Silvia Forroova, brand director at Informa Markets, said:

“It’s been a remarkable few years in terms of FDA approvals, but what we are now seeing is that this pipeline of new drugs has helped drive increased innovation in packaging and drug delivery devices. In fact, we are witnessing this trend first-hand at Pharmapack with many smaller and nimble companies bringing forward novel delivery systems and advanced packaging solutions, and we now have the data to back it up.”

The Pharmapack event has become integral to the industry in Europe, with a new innovations community centered around its Pharmapack Awards and the Start-up Hub – both of which have grown in prominence as a more diverse range of companies bring advanced innovations to patients. In total, more than 400 exhibitors from 31 countries will be present, running alongside over 40 high-level conference presentations, welcoming 5,500 attendees.

Entries for the 2020 Pharmapack Awards are now open across both the ‘Exhibitor Innovation’ and ‘Health Products’ categories with a closing date in late November 2019. The Start-up Hub also returns providing young start-up companies the benefit of valuable networking and learning opportunities at a low-cost price.

With new delivery devices proliferating and a changing drugs pipeline for low volume products, Pharmapack is also introducing the ‘Machines at Work’ area to help bring attendees together with the new machines and packaging solutions to aid commercializing the next generation of products.

Forroova added:

“Showcasing many diverse breakthroughs in the market, we are also running the start-up pitches so that we can bring together early-stage innovators with major pharma and drug delivery companies. It’s free to apply for ‘dragon’s den’ style opportunity for early-stage innovators to get in front of potential partners and investors. In the last few years undoubtedly Pharmapack has seen an increase in innovators – both big and small. From new patient-centric technologies, more sustainable packaging and, of course, connected devices all offering new opportunities, it’s a golden era and never has the pace of innovation been so great. As a result, attendees now visit Pharmapack specifically with the expectation to see the latest packaging, machinery and drug delivery device solutions. What we expect is that this trend will continue to be mirrored by our Pharmapack Innovation Index as the industry is shifting, with Europe increasingly seen as a primary source of innovation.”

Pharmapack Europe will return in 2020 and will be held from 5-6 February in the Paris Expo, Porte de Versailles.

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more